It is traditional at this time of year to ponder a little on the future, as well as to review the happenings of the last twelve months - the achievements, success stories, the disappointments, and matters left unfinished. To me, it is imperative that emerging biotech companies not only learn how to commercialise and export their products highly effectively, but maintain top standards of honesty
... [Show full abstract] and openness at all times.